News
-
-
PRESS RELEASE
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
Moderna submits application to FDA for review of Spikevax 2025-2026 formula targeting SARS-CoV-2 variant LP.8.1, based on FDA guidance for COVID-19 vaccine update. Learn more about Moderna's innovative mRNA technology -
-
PRESS RELEASE
Quadient SA: Availability and consultation of the information relating to the Ordinary Annual and Extraordinary General Meeting to be held on 13 June 2025
Quadient SA announces Ordinary Annual and Extraordinary General Meeting on 13 June 2025. Shareholders to participate physically or via live broadcast. Meeting details available on company website -
-
-
-
-
-